Researchers at the University of Central Florida report that genetic mutations linked to Alzheimer's can interfere with the nerves that control muscles, even when the brain and spinal cord are absent from the experimental system. The study, led by James Hickman and Xiufang "Nadine" Guo with scientists at the company Hesperos, was funded by the National Institute on Aging and published in Alzheimer's & Dementia: The Journal of the Alzheimer's Association.
The work was motivated by a longstanding clinical observation. Some people develop changes in balance, coordination, and gait years before clear memory or thinking problems appear. The open question was whether those movement problems are simply a downstream result of brain damage, or whether the disease can reach peripheral nerves directly. The team focused on familial Alzheimer's, a rare inherited form that typically begins between ages 40 and 65.
To test this, the scientists used "human-on-a-chip" systems, miniature platforms that bring different human cell types together under controlled conditions. They built a model of the neuromuscular junction, the point where a motor neuron signals a muscle cell, and combined healthy muscle cells with motor neurons derived from stem cells carrying familial Alzheimer's mutations. The researchers then measured how consistently nerve signals produced muscle contractions and how long the muscles kept contracting before fatiguing. Both measures showed impairment, which the authors read as evidence that the mutations can cause nerve-to-muscle problems independent of central nervous system damage.
Why this matters is partly practical. If movement changes can appear early, tests of walking, coordination, or nerve-muscle function might someday help flag disease-related changes sooner. The authors also point out that drugs aimed only at the brain may not correct problems in the rest of the body, which could shape how treatments are designed and evaluated.
The authors are careful about the limits. The experiments do not show that these changes occur before memory loss in patients, and it remains to be seen how closely a cell-based model mirrors disease progression in people, especially in the more common forms of Alzheimer's.